ADAR1 Capital Management
Latest statistics and disclosures from ADAR1 Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALNY, BOXX, ROIV, SPY, PTGX, and represent 40.12% of ADAR1 Capital Management's stock portfolio.
- Added to shares of these 10 stocks: BOXX (+$34M), ALNY (+$28M), SPY (+$27M), PTGX (+$17M), ROIV (+$16M), BBIO (+$11M), CYTK (+$11M), Merrimack Pharma (+$5.2M), AVRO, BGNE.
- Started 124 new stock positions in KALV, DYN, KRYS, ANAB, CCOI, LLY, CALC, CNTX, GHRS, JANX.
- Reduced shares in these 10 stocks: KROS (-$23M), VKTX (-$20M), RPRX (-$18M), MRK (-$7.1M), Mirati Therapeutics (-$6.3M), ABUS, CERE, Karuna Therapeutics Ord, CLRB, Alteryx.
- Sold out of its positions in ANIP, Alpine Immune Sciences, ALT, Alteryx, ANEB, ARGX, Flamel Technologies Sa, BCLI, CETU, CLNN.
- ADAR1 Capital Management was a net buyer of stock by $127M.
- ADAR1 Capital Management has $441M in assets under management (AUM), dropping by 57.52%.
- Central Index Key (CIK): 0001940272
Tip: Access up to 7 years of quarterly data
Positions held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ADAR1 Capital Management
ADAR1 Capital Management holds 247 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 14.4 | $64M | +78% | 426k | 149.45 |
|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 7.7 | $34M | NEW | 318k | 106.46 |
|
| Roivant Sciences SHS (ROIV) | 6.7 | $29M | +121% | 2.8M | 10.54 |
|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 6.2 | $27M | NEW | 52k | 523.07 |
|
| Protagonist Therapeutics (PTGX) | 5.2 | $23M | +291% | 786k | 28.93 |
|
| Cytokinetics Com New (CYTK) | 5.1 | $23M | +90% | 322k | 70.11 |
|
| Keros Therapeutics (KROS) | 5.1 | $22M | -50% | 338k | 66.20 |
|
| Royalty Pharma Shs Class A (RPRX) | 5.0 | $22M | -45% | 721k | 30.37 |
|
| Bridgebio Pharma (BBIO) | 3.9 | $17M | +197% | 551k | 30.92 |
|
| Merrimack Pharmaceuticals In Com New | 3.0 | $13M | +64% | 902k | 14.77 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.7 | $7.3M | +5% | 49k | 151.17 |
|
| Arbutus Biopharma (ABUS) | 1.2 | $5.4M | -43% | 2.1M | 2.58 |
|
| Avrobio Ord (AVRO) | 1.1 | $5.1M | +7786% | 4.0M | 1.28 |
|
| Beigene Sponsored Adr (BGNE) | 1.1 | $4.9M | +1453% | 32k | 156.39 |
|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 1.0 | $4.4M | NEW | 10k | 444.01 |
|
| Alkermes SHS (ALKS) | 1.0 | $4.2M | NEW | 157k | 27.07 |
|
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.0 | $4.2M | NEW | 404k | 10.40 |
|
| Sarepta Therapeutics (SRPT) | 0.9 | $4.2M | +300% | 32k | 129.46 |
|
| Endeavor Group Hldgs Cl A Com (EDR) | 0.9 | $4.0M | +6110% | 155k | 25.73 |
|
| Achieve Life Sciences (ACHV) | 0.9 | $4.0M | NEW | 875k | 4.54 |
|
| Fusion Pharmaceuticals | 0.9 | $3.8M | NEW | 177k | 21.32 |
|
| Absci Corp (ABSI) | 0.8 | $3.3M | NEW | 587k | 5.68 |
|
| Applied Therapeutics (APLT) | 0.8 | $3.3M | NEW | 487k | 6.80 |
|
| Edgewise Therapeutics (EWTX) | 0.7 | $3.3M | NEW | 181k | 18.24 |
|
| Fulcrum Therapeutics (FULC) | 0.7 | $3.2M | -46% | 340k | 9.44 |
|
| Q32 Bio (QTTB) | 0.7 | $3.2M | NEW | 188k | 17.04 |
|
| Cerevel Therapeutics Hldng I (CERE) | 0.7 | $3.1M | -53% | 75k | 42.27 |
|
| Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 0.7 | $3.0M | 33k | 91.80 |
|
|
| Pfizer (PFE) | 0.7 | $3.0M | +76% | 106k | 27.75 |
|
| Vanguard Bd Index Fds Vanguard Ultra (VUSB) | 0.6 | $2.7M | +9% | 55k | 49.55 |
|
| J P Morgan Exchange Traded F Ultra Shrt Inc (JPST) | 0.6 | $2.7M | +10% | 54k | 50.45 |
|
| Ishares Tr Short Treas Bd (SHV) | 0.6 | $2.7M | 25k | 110.54 |
|
|
| Solid Biosciences Com New (SLDB) | 0.6 | $2.7M | +20220% | 203k | 13.32 |
|
| Wisdomtree Tr Floatng Rat Trea (USFR) | 0.6 | $2.7M | -5% | 53k | 50.29 |
|
| Cellectar Biosciences Com New (CLRB) | 0.6 | $2.6M | -53% | 643k | 3.98 |
|
| Omniab (OABI) | 0.6 | $2.4M | -5% | 452k | 5.42 |
|
| Guardant Health (GH) | 0.5 | $2.4M | NEW | 117k | 20.63 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $2.3M | NEW | 207k | 11.30 |
|
| Regeneron Pharmaceuticals (REGN) | 0.5 | $2.2M | NEW | 2.3k | 962.49 |
|
| Ibio Con New (IBIO) | 0.5 | $2.2M | NEW | 600k | 3.65 |
|
| Corteva (CTVA) | 0.5 | $2.2M | -35% | 37k | 57.67 |
|
| Beyond Air (XAIR) | 0.5 | $2.1M | NEW | 1.2M | 1.74 |
|
| Immunovant (IMVT) | 0.4 | $2.0M | -54% | 61k | 32.31 |
|
| Ligand Pharmaceuticals Com New (LGND) | 0.4 | $2.0M | NEW | 27k | 73.10 |
|
| Ssga Active Etf Tr Ult Sht Trm Bd (ULST) | 0.4 | $1.9M | -22% | 48k | 40.50 |
|
| Spyre Therapeutics Com New (SYRE) | 0.4 | $1.9M | +668% | 50k | 37.93 |
|
| Schrodinger (SDGR) | 0.4 | $1.7M | +3079% | 64k | 27.00 |
|
| Spero Therapeutics (SPRO) | 0.4 | $1.6M | -13% | 927k | 1.72 |
|
| Uniqure Nv SHS (QURE) | 0.3 | $1.5M | NEW | 293k | 5.20 |
|
| Apellis Pharmaceuticals (APLS) | 0.3 | $1.5M | NEW | 26k | 58.78 |
|
| Eli Lilly & Co. (LLY) | 0.3 | $1.5M | NEW | 1.9k | 777.96 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.3 | $1.4M | -8% | 102k | 14.11 |
|
| Ngm Biopharmaceuticals | 0.3 | $1.3M | NEW | 817k | 1.59 |
|
| Viking Therapeutics (VKTX) | 0.3 | $1.2M | -94% | 14k | 82.00 |
|
| Kiniksa Pharmaceuticals Com Cl A | 0.3 | $1.2M | -43% | 60k | 19.73 |
|
| Envveno Medical (NVNO) | 0.2 | $1.1M | NEW | 202k | 5.44 |
|
| Arvinas Ord (ARVN) | 0.2 | $1.1M | +3175% | 26k | 41.28 |
|
| Delcath Sys Com New (DCTH) | 0.2 | $1.0M | -5% | 219k | 4.77 |
|
| AngioDynamics (ANGO) | 0.2 | $900k | +15% | 153k | 5.87 |
|
| Silence Therapeutics Ads (SLN) | 0.2 | $866k | +21000% | 40k | 21.60 |
|
| Gossamer Bio (GOSS) | 0.2 | $865k | +2% | 733k | 1.18 |
|
| Global Star Acquisition Class A Com (GLST) | 0.2 | $857k | 80k | 10.71 |
|
|
| Voyager Therapeutics (VYGR) | 0.2 | $852k | -50% | 92k | 9.31 |
|
| IsoRay | 0.2 | $805k | +1503% | 677k | 1.19 |
|
| Keen Vision Acquisition Corp Unit 99/99/9999 (KVACU) | 0.2 | $788k | 75k | 10.51 |
|
|
| Actinium Pharmaceuticals (ATNM) | 0.2 | $783k | NEW | 100k | 7.83 |
|
| Kiora Pharmaceuticals Com New | 0.2 | $777k | NEW | 1.1M | 0.71 |
|
| Acasti Pharma Cl A (ACST) | 0.2 | $745k | +529% | 217k | 3.42 |
|
| Morphic Hldg (MORF) | 0.2 | $694k | NEW | 20k | 35.20 |
|
| Kymera Therapeutics (KYMR) | 0.1 | $643k | NEW | 16k | 40.20 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.1 | $628k | NEW | 16k | 39.24 |
|
| Therapeuticsmd Com New (TXMD) | 0.1 | $623k | 272k | 2.29 |
|
|
| West Pharmaceutical Services (WST) | 0.1 | $594k | NEW | 1.5k | 395.71 |
|
| Indivior Ord (INDV) | 0.1 | $591k | +14% | 28k | 21.42 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.1 | $537k | +1140% | 12k | 43.33 |
|
| Tmt Acquisition Corp SHS (TMTC) | 0.1 | $535k | 50k | 10.69 |
|
|
| Janux Therapeutics (JANX) | 0.1 | $527k | NEW | 14k | 37.65 |
|
| Nurix Therapeutics (NRIX) | 0.1 | $523k | NEW | 36k | 14.70 |
|
| Ab Active Etfs Ultra Short Incm (YEAR) | 0.1 | $505k | 10k | 50.52 |
|
|
| Stevanato Group S P A Ord Shs (STVN) | 0.1 | $498k | NEW | 16k | 32.10 |
|
| Pgim Etf Tr Pgim Ultra Sh Bd (PULS) | 0.1 | $497k | 10k | 49.70 |
|
|
| Equillium (EQ) | 0.1 | $482k | +3111% | 209k | 2.31 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.1 | $475k | -63% | 90k | 5.28 |
|
| Aerovate Therapeutics (AVTE) | 0.1 | $470k | NEW | 16k | 29.57 |
|
| Tyra Biosciences (TYRA) | 0.1 | $464k | NEW | 28k | 16.40 |
|
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $460k | NEW | 41k | 11.23 |
|
| Intelligent Bio Solutions In (INBS) | 0.1 | $457k | NEW | 108k | 4.22 |
|
| Glycomimetics Put Option (GLYC) | 0.1 | $417k | NEW | 139k | 3.00 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $411k | +19% | 145k | 2.84 |
|
| Apogee Therapeutics (APGE) | 0.1 | $399k | NEW | 6.0k | 66.45 |
|
| Milestone Pharmaceuticals (MIST) | 0.1 | $362k | NEW | 203k | 1.79 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $359k | -88% | 14k | 24.90 |
|
| Zai Lab Adr (ZLAB) | 0.1 | $352k | +10% | 22k | 16.02 |
|
| Vyne Therapeutics (VYNE) | 0.1 | $338k | NEW | 110k | 3.07 |
|
| Cytomx Therapeutics (CTMX) | 0.1 | $338k | NEW | 155k | 2.18 |
|
| Oak Woods Acquisition Corp Cl A (OAKU) | 0.1 | $323k | 30k | 10.75 |
|
|
| Screaming Eagle Acquisitn Class A Ord Shs | 0.1 | $321k | 30k | 10.70 |
|
|
| Alector (ALEC) | 0.1 | $316k | NEW | 53k | 6.02 |
|
| Mineralys Therapeutics (MLYS) | 0.1 | $310k | NEW | 24k | 12.91 |
|
| Jvspac Acquisition Corp Unit 03/11/2024 (JVSAU) | 0.1 | $309k | NEW | 30k | 10.30 |
|
| Alphabet Cap Stk Cl A (GOOGL) | 0.1 | $302k | NEW | 2.0k | 150.93 |
|
| Spruce Biosciences (SPRB) | 0.1 | $287k | NEW | 365k | 0.79 |
|
| Context Therapeutics (CNTX) | 0.1 | $284k | NEW | 206k | 1.38 |
|
| Digital World Acquisition Co Class A Call Option (DJT) | 0.1 | $279k | NEW | 4.5k | 61.96 |
|
| Sanofi Sponsored Adr (SNY) | 0.1 | $267k | NEW | 5.5k | 48.60 |
|
| Tourmaline Bio (TRML) | 0.1 | $265k | NEW | 12k | 22.90 |
|
| Cogent Communications Hldgs Com New (CCOI) | 0.1 | $261k | NEW | 4.0k | 65.33 |
|
| Iron Horse Acquisitions Corp Unit 10/15/2028 (IROHU) | 0.1 | $255k | 25k | 10.19 |
|
|
| Pimco Etf Tr 25yr+ Zero U S (ZROZ) | 0.1 | $238k | NEW | 3.0k | 79.25 |
|
| Female Health (VERU) | 0.1 | $235k | -32% | 336k | 0.70 |
|
| Option Care Health Com New (OPCH) | 0.1 | $235k | NEW | 7.0k | 33.54 |
|
| Algonquin Power & Utilities equs (AQN) | 0.1 | $234k | -26% | 37k | 6.32 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.0 | $215k | NEW | 15k | 14.30 |
|
| Kezar Life Sciences (KZR) | 0.0 | $213k | NEW | 237k | 0.90 |
|
| Pasithea Therapeutics Corp Com New (KTTA) | 0.0 | $201k | NEW | 28k | 7.25 |
|
| Ishares Tr 20 Yr Tr Bd Etf (TLT) | 0.0 | $189k | NEW | 2.0k | 94.62 |
|
| Wave Life Sciences SHS (WVE) | 0.0 | $185k | NEW | 30k | 6.17 |
|
| Immatics SHS (IMTX) | 0.0 | $170k | -26% | 16k | 10.51 |
|
| Greenlight Capital Re Class A (GLRE) | 0.0 | $167k | -60% | 13k | 12.47 |
|
| Feutune Light Acquisition Cl A Com (AIEV) | 0.0 | $163k | 15k | 10.87 |
|
|
| Abbott Laboratories (ABT) | 0.0 | $159k | NEW | 1.4k | 113.66 |
|
| Nuvei Corporation Sub Vtg Shs (NVEI) | 0.0 | $158k | NEW | 5.0k | 31.62 |
|
| Black Hawk Acquisition Corp Unit 99/99/9999 (BKHAU) | 0.0 | $152k | NEW | 15k | 10.15 |
|
| Cabaletta Bio (CABA) | 0.0 | $152k | NEW | 8.9k | 17.06 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $151k | NEW | 3.0k | 50.23 |
|
| Prothena Corp SHS (PRTA) | 0.0 | $148k | 6.0k | 24.77 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $141k | -17% | 3.3k | 42.86 |
|
| Vaxcyte (PCVX) | 0.0 | $137k | +1900% | 2.0k | 68.31 |
|
| McKesson Corporation (MCK) | 0.0 | $134k | NEW | 250.00 | 536.85 |
|
| Gh Research Ordinary Shares (GHRS) | 0.0 | $134k | NEW | 13k | 10.66 |
|
| Avalo Therapeutics Com New (AVTX) | 0.0 | $131k | NEW | 6.0k | 21.75 |
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $126k | NEW | 2.9k | 43.35 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.0 | $125k | -79% | 44k | 2.87 |
|
| Biohaven (BHVN) | 0.0 | $120k | NEW | 2.2k | 54.69 |
|
| Forte Biosciences (FBRX) | 0.0 | $119k | NEW | 171k | 0.70 |
|
| Kalvista Pharmaceuticals (KALV) | 0.0 | $119k | NEW | 10k | 11.86 |
|
| EXACT Sciences Corporation (EXAS) | 0.0 | $117k | NEW | 1.7k | 69.06 |
|
| Organon & Co Common Stock (OGN) | 0.0 | $113k | NEW | 6.0k | 18.80 |
|
| Jd.com Spon Adr Cl A (JD) | 0.0 | $110k | NEW | 4.0k | 27.39 |
|
| Four Leaf Acquisition Corp Com Cl A (FORL) | 0.0 | $107k | 10k | 10.72 |
|
|
| Acelyrin (SLRN) | 0.0 | $101k | +114% | 15k | 6.75 |
|
| Longboard Pharmaceuticals In (LBPH) | 0.0 | $99k | +472% | 4.6k | 21.60 |
|
| Kensington Capital Acquisiti Shs Cl A (KCGI) | 0.0 | $98k | 9.0k | 10.84 |
|
|
| Lexaria Bioscience Corp Com New (LEXX) | 0.0 | $97k | +1537% | 27k | 3.63 |
|
| Nextcure (NXTC) | 0.0 | $96k | -28% | 43k | 2.23 |
|
| Bausch Plus Lomb Corp Common Shares (BLCO) | 0.0 | $92k | +51% | 5.3k | 17.30 |
|
| Cg Oncology (CGON) | 0.0 | $90k | NEW | 2.1k | 43.90 |
|
| Altria (MO) | 0.0 | $87k | -66% | 2.0k | 43.62 |
|
| Mitek Sys Com New (MITK) | 0.0 | $79k | -26% | 5.6k | 14.10 |
|
| 99 Acquisition Group Unit 99/99/9999 | 0.0 | $79k | 7.5k | 10.49 |
|
|
| Ai Transn Acquisition Corp Unit 99/99/9999 (AITRU) | 0.0 | $78k | 7.5k | 10.42 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $74k | 5.0k | 14.82 |
|
|
| Adicet Bio (ACET) | 0.0 | $73k | NEW | 31k | 2.35 |
|
| Howard Hughes Holdings (HHH) | 0.0 | $73k | -66% | 1.0k | 72.62 |
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $71k | NEW | 2.4k | 29.36 |
|
| Anaptysbio Inc Common (ANAB) | 0.0 | $68k | NEW | 3.0k | 22.52 |
|
| Rapt Therapeutics Put Option (RAPT) | 0.0 | $67k | 7.5k | 8.98 |
|
|
| Tg Therapeutics (TGTX) | 0.0 | $66k | NEW | 4.4k | 15.21 |
|
| Astria Therapeutics (ATXS) | 0.0 | $66k | -97% | 4.7k | 14.07 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $64k | NEW | 2.0k | 31.86 |
|
| Bausch Health Companies Call Option (BHC) | 0.0 | $64k | NEW | 6.0k | 10.61 |
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $63k | -33% | 2.0k | 31.62 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.0 | $62k | NEW | 1.0k | 62.24 |
|
| Evotec Sponsored Ads (EVO) | 0.0 | $60k | NEW | 7.7k | 7.83 |
|
| Kohl's Corporation (KSS) | 0.0 | $58k | 2.0k | 29.15 |
|
|
| Disc Medicine (IRON) | 0.0 | $56k | NEW | 896.00 | 62.26 |
|
| Krystal Biotech (KRYS) | 0.0 | $53k | NEW | 300.00 | 177.93 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.0 | $53k | NEW | 2.5k | 21.07 |
|
| Kraneshares Trust Csi Chi Internet (KWEB) | 0.0 | $53k | 2.0k | 26.25 |
|
|
| Fibrogen (FGEN) | 0.0 | $50k | NEW | 21k | 2.35 |
|
| Ovid Therapeutics (OVID) | 0.0 | $50k | +24% | 16k | 3.05 |
|
| Ikena Oncology (IKNA) | 0.0 | $50k | NEW | 35k | 1.42 |
|
| Amplify Energy Corp (AMPY) | 0.0 | $47k | 7.1k | 6.61 |
|
|
| Pharvaris N V (PHVS) | 0.0 | $46k | NEW | 2.0k | 23.11 |
|
| Insmed Com Par $.01 Put Option (INSM) | 0.0 | $46k | NEW | 1.7k | 27.13 |
|
| Ultra Clean Holdings (UCTT) | 0.0 | $46k | NEW | 1.0k | 45.94 |
|
| Akero Therapeutics (AKRO) | 0.0 | $46k | -88% | 1.8k | 25.26 |
|
| Miragen Therapeutics (VRDN) | 0.0 | $45k | NEW | 2.6k | 17.51 |
|
| Elevation Oncology (ELEV) | 0.0 | $44k | NEW | 8.6k | 5.13 |
|
| Pyxis Oncology Common Stock (PYXS) | 0.0 | $43k | NEW | 10k | 4.26 |
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $42k | -98% | 4.3k | 9.91 |
|
| Denali Therapeutics (DNLI) | 0.0 | $41k | NEW | 2.0k | 20.52 |
|
| Adverum Biotechnologies Com New (ADVM) | 0.0 | $40k | NEW | 2.8k | 14.14 |
|
| Merck & Co (MRK) | 0.0 | $40k | -99% | 300.00 | 131.95 |
|
| Stoke Therapeutics (STOK) | 0.0 | $39k | NEW | 2.9k | 13.50 |
|
| Magnachip Semiconductor Corp (MX) | 0.0 | $39k | 7.0k | 5.58 |
|
|
| Igm Biosciences (IGMS) | 0.0 | $39k | NEW | 4.0k | 9.65 |
|
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.0 | $37k | NEW | 59k | 0.62 |
|
| 89bio (ETNB) | 0.0 | $36k | +611% | 3.1k | 11.64 |
|
| Hookipa Pharma Inc equity | 0.0 | $36k | NEW | 50k | 0.71 |
|
| Neurogene (NGNE) | 0.0 | $34k | -87% | 661.00 | 50.90 |
|
| Rallybio Corp (RLYB) | 0.0 | $33k | NEW | 18k | 1.85 |
|
| Terns Pharmaceuticals (TERN) | 0.0 | $33k | -61% | 5.0k | 6.56 |
|
| Amphastar Pharmaceuticals (AMPH) | 0.0 | $31k | NEW | 700.00 | 43.91 |
|
| Liquidia Corporation Com New (LQDA) | 0.0 | $30k | NEW | 2.0k | 14.75 |
|
| Design Therapeutics (DSGN) | 0.0 | $29k | +260% | 7.2k | 4.03 |
|
| Cortexyme (QNCX) | 0.0 | $28k | NEW | 27k | 1.06 |
|
| Savara (SVRA) | 0.0 | $28k | NEW | 5.6k | 4.98 |
|
| Ventyx Biosciences (VTYX) | 0.0 | $28k | -61% | 5.0k | 5.50 |
|
| Perrigo SHS (PRGO) | 0.0 | $26k | NEW | 800.00 | 32.19 |
|
| NCR Corporation (VYX) | 0.0 | $25k | 2.0k | 12.63 |
|
|
| Oncternal Therapeutics Com New (ONCT) | 0.0 | $22k | NEW | 2.5k | 9.00 |
|
| Compass Therapeutics (CMPX) | 0.0 | $20k | NEW | 10k | 1.98 |
|
| Zymeworks Del (ZYME) | 0.0 | $20k | NEW | 1.9k | 10.52 |
|
| Ncr Atleos Corporation Com Shs (NATL) | 0.0 | $20k | 1.0k | 19.75 |
|
|
| Akebia Therapeutics Put Option (AKBA) | 0.0 | $18k | NEW | 9.7k | 1.83 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $17k | +100% | 600.00 | 28.60 |
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $17k | NEW | 10k | 1.70 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.0 | $14k | NEW | 200.00 | 67.75 |
|
| Steel Partners Hldgs Ltd Prtrship U (SPLP) | 0.0 | $14k | 341.00 | 39.65 |
|
|
| Novo-nordisk A S Adr (NVO) | 0.0 | $13k | -98% | 100.00 | 128.40 |
|
| Xeris Pharmaceuticals (XERS) | 0.0 | $11k | NEW | 5.1k | 2.21 |
|
| Global Star Acquisition Right 06/21/2024 (GLSTR) | 0.0 | $11k | 118k | 0.09 |
|
|
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $10k | NEW | 2.0k | 5.01 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $9.2k | NEW | 500.00 | 18.49 |
|
| Tmt Acquisition Corp Right 03/27/2028 (TMTCR) | 0.0 | $9.0k | 50k | 0.18 |
|
|
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.0 | $8.7k | NEW | 1.0k | 8.67 |
|
| Dyne Therapeutics (DYN) | 0.0 | $8.4k | NEW | 297.00 | 28.39 |
|
| Protara Therapeutics Com Stk (TARA) | 0.0 | $8.0k | -8% | 2.0k | 4.01 |
|
| Surrozen Com New (SRZN) | 0.0 | $7.1k | NEW | 450.00 | 15.71 |
|
| Bolt Biotherapeutics (BOLT) | 0.0 | $7.0k | NEW | 5.0k | 1.40 |
|
| Bluebird Bio (BLUE) | 0.0 | $6.4k | NEW | 5.0k | 1.28 |
|
| Oak Woods Acquisition Corp Right 03/23/2028 (OAKUR) | 0.0 | $6.0k | 30k | 0.20 |
|
|
| Masimo Corporation (MASI) | 0.0 | $5.6k | -34% | 38.00 | 146.84 |
|
| 2seventy Bio Common Stock (TSVT) | 0.0 | $5.4k | 1.0k | 5.35 |
|
|
| Addex Therapeutics Sponsored Ads (ADXN) | 0.0 | $5.0k | NEW | 390.00 | 12.80 |
|
| Beyond Meat (BYND) | 0.0 | $4.8k | NEW | 577.00 | 8.28 |
|
| Geron Corporation (GERN) | 0.0 | $4.3k | -92% | 1.3k | 3.30 |
|
| Ichor Holdings SHS (ICHR) | 0.0 | $4.2k | NEW | 108.00 | 38.62 |
|
| Calcimedica Com New (CALC) | 0.0 | $3.2k | NEW | 781.00 | 4.16 |
|
| Relmada Therapeutics (RLMD) | 0.0 | $2.8k | -98% | 601.00 | 4.65 |
|
| Talis Biomedical Corp Com New (TLIS) | 0.0 | $2.6k | NEW | 300.00 | 8.75 |
|
| Embrace Change Acquisitn Cor Right 10/25/2026 (EMCGR) | 0.0 | $2.5k | 18k | 0.14 |
|
|
| Karyopharm Therapeutics (KPTI) | 0.0 | $2.2k | NEW | 1.5k | 1.51 |
|
| Global Star Acquisition *w Exp 07/15/202 (GLSTW) | 0.0 | $2.0k | 120k | 0.02 |
|
|
| Feutune Light Acquisition Right 06/01/2029 (FLFVR) | 0.0 | $1.3k | 15k | 0.09 |
|
|
| Futuretech Ii Acquisition *w Exp 08/18/202 (FTIIW) | 0.0 | $1.2k | 30k | 0.04 |
|
|
| Ecd Automotive Design *w Exp 12/12/202 (ECDAW) | 0.0 | $818.159600 | 33k | 0.03 |
|
|
| Travere Therapeutics (TVTX) | 0.0 | $771.000000 | 100.00 | 7.71 |
|
|
| Pono Cap Two *w Exp 99/99/999 (SBCWW) | 0.0 | $693.000000 | 20k | 0.04 |
|
|
| Cetus Cap Acquisition Corp Right 03/31/2024 (CETUR) | 0.0 | $604.879000 | 5.0k | 0.12 |
|
|
| Oak Woods Acquisition Corp *w Exp 99/99/999 (OAKUW) | 0.0 | $600.000000 | 30k | 0.02 |
|
|
| Feutune Light Acquisition *w Exp 06/01/202 (FLFVW) | 0.0 | $510.000000 | 15k | 0.03 |
|
|
| Embrace Change Acquisitn Cor *w Exp 10/25/202 (EMCGW) | 0.0 | $406.800000 | 18k | 0.02 |
|
|
| Four Leaf Acquisition Corp *w Exp 03/15/202 (FORLW) | 0.0 | $389.915700 | 9.5k | 0.04 |
|
|
| Aimfinity Investment Corp I *w Exp 99/99/999 (AIMAW) | 0.0 | $234.000000 | 18k | 0.01 |
|
|
| Cetus Cap Acquisition Corp *w Exp 01/31/202 (CETUW) | 0.0 | $95.000000 | 5.0k | 0.02 |
|
Past Filings by ADAR1 Capital Management
SEC 13F filings are viewable for ADAR1 Capital Management going back to 2023
- ADAR1 Capital Management 2024 Q1 filed May 15, 2024
- ADAR1 Capital Management 2023 Q4 filed Feb. 14, 2024